Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On
© Edgar Online, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.2 USD | +0.63% | +3.90% | +12.68% |
15/05 | Transcript : Aytu BioPharma, Inc., Q3 2024 Earnings Call, May 15, 2024 | |
15/05 | Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q3 Revenue $18M, vs. Street Est of $17.4M | MT |
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On
© Edgar Online, source
1st Jan change | Capi. | |
---|---|---|
+12.68% | 1.78Cr | |
+38.51% | 73TCr | |
+31.74% | 60TCr | |
-6.23% | 35TCr | |
+18.78% | 33TCr | |
+1.35% | 28TCr | |
+16.00% | 24TCr | |
+8.44% | 20TCr | |
-5.97% | 20TCr | |
+6.19% | 16TCr |